These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35228982)

  • 21. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
    Patnaik MM; Lasho T
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):460-464. PubMed ID: 33275673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
    Singh ZN; Post GR; Kiwan E; Maddox AM
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.
    Muramatsu H; Makishima H; Maciejewski JP
    Semin Oncol; 2012 Feb; 39(1):67-73. PubMed ID: 22289493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.
    Kohlmann A; Grossmann V; Klein HU; Schindela S; Weiss T; Kazak B; Dicker F; Schnittger S; Dugas M; Kern W; Haferlach C; Haferlach T
    J Clin Oncol; 2010 Aug; 28(24):3858-65. PubMed ID: 20644105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.
    Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P
    J Clin Pathol; 2009 Sep; 62(9):798-801. PubMed ID: 19734476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of a Clonal T-Cell Population in a Case of Chronic Myelomonocytic Leukemia.
    Patil A; Wanve B; Kar P; Velusamy S
    Clin Med Insights Blood Disord; 2021; 14():2634853521991509. PubMed ID: 33628070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
    Jian J; Qiao Y; Li Y; Guo Y; Ma H; Liu B
    Clin Transl Oncol; 2021 Sep; 23(9):1731-1742. PubMed ID: 33861431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent chronic myelomonocytic leukemia and gastric carcinoma: a case report and literature review.
    Fang C; Chen Z; Li J; Yu L; Wang L
    AME Case Rep; 2023; 7():37. PubMed ID: 37942038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related mutations and chronic myelomonocytic leukemia.
    Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
    Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
    Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
    Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
    Padron E; Steensma DP
    Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
    Gur HD; Loghavi S; Garcia-Manero G; Routbort M; Kanagal-Shamanna R; Quesada A; Khogeer H; Pierce S; Medeiros LJ; Kantarjian H; Khoury JD
    Am J Surg Pathol; 2018 Jun; 42(6):799-806. PubMed ID: 29596070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
    Jankowska AM; Makishima H; Tiu RV; Szpurka H; Huang Y; Traina F; Visconte V; Sugimoto Y; Prince C; O'Keefe C; Hsi ED; List A; Sekeres MA; Rao A; McDevitt MA; Maciejewski JP
    Blood; 2011 Oct; 118(14):3932-41. PubMed ID: 21828135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
    Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
    Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Case of Chronic Myelomonocytic Leukemia Unmasked After Receiving J&J COVID-19 Vaccine.
    Veeraballi S; Patel A; Are G; Ramahi A; Chittamuri S; Shaaban H
    Cureus; 2022 Jun; 14(6):e26070. PubMed ID: 35865440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
    Patnaik MM; Tefferi A
    Mayo Clin Proc; 2016 Feb; 91(2):259-72. PubMed ID: 26848006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico.
    Jiang Z; Sun X; Wu Z; Alhatem A; Zheng R; Liu D; Wang Y; Kumar D; Xia C; You B; Wang H; Liu C; Jiang JG
    Oncotarget; 2020 Nov; 11(47):4411-4420. PubMed ID: 33315966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2022 Mar; 97(3):352-372. PubMed ID: 34985762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2020 Jan; 95(1):97-115. PubMed ID: 31736132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.